Le Lézard
Classified in: Science and technology
Subject: SVY

The global compound management market is expected to reach US$ 691.41 Mn in 2027 from US$ 220.19 Mn in 2018. The compound management market is estimated to grow with a CAGR of 14.2% from 2019-2027


NEW YORK, Sept. 18, 2019 /PRNewswire/ --

Compound Management Market to 2027 ? Global Analysis and Forecasts by Product & Services, Sample Type, Application, End User, and Geography

Read the full report: https://www.reportlinker.com/p05815390/?utm_source=PRN

The global compound management market is expected to reach US$ 691.41 Mn in 2027 from US$ 220.19 Mn in 2018. The compound management market is estimated to grow with a CAGR of 14.2% from 2019-2027.
The market is driven by factors such as, rising drug discovery activities incorporation of artificial intelligence (AI) for faster drug development process. However, lack of skilled professionals may limit the growth of the market to a certain extent.
The compound management products are used for sample acquisition, storage with high-throughput compound screening.A modular automated sample storage system is efficiently designed for meeting the needs of the most challenging sample and compound management applications at temperatures to -20°C.

The system can handle a broad range of labware types, which include vials, tubes, and plates, for accommodating current and future workflows. The advantages of system include rapid access storage that is scalable and easy to incorporate with complimentary automation for efficient sample management of growing compound libraries.
Though there are many advantages of compound management the instrument is expensive to acquire.To operate such expensive devices trained professional are required.

Companies supplying these devices provide the basic training required to operate. Hence, high price as well as dearth of trained professionals for the handling of these instrument is anticipated to hinder growth of the compound management market.
Global compound management market was segmented by product & services, sample type, application and end user. The product and services were segmented into compound/sample management products which include instruments, automated compound/sample storage systems, manual compound/sample storage systems, automated liquid handling systems, software and services. By sample type it was segmented in chemical compounds and biosamples. By application it is categorized in drug discovery, gene synthesis and biobanking. By end user pharmaceutical companies, biopharmaceutical companies, contract research organization (CRO's) and others.
Some of the major primary and secondary sources included in the report are, Department of Biotechnology, Canadian Institutes of Health Research, Indian Council of Medical Research, Federation of Pharmaceutical Industries and Associations, Association of the Italian Pharmaceutical Industry, Bio Industry Association among others.

Read the full report: https://www.reportlinker.com/p05815390/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE ReportBuyer


These press releases may also interest you

at 07:30
Orezone Gold Corporation (the "Company" or "Orezone") is pleased to provide drill results from its Bomboré Gold Mine located in central Burkina Faso. The results are part of Orezone's ongoing infill and advanced grade control program which was...

at 07:25
Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced it has secured funding from the Bill & Melinda Gates Foundation ("the Gates Foundation" or "the...

at 07:20
Onconic Therapeutics, a leading biotechnology company in Korea, today announced that the Ministry of Food and Drug Safety (MFDS) of Korea has approved JAQBO (zastaprazan citrate) for the treatment of erosive gastroesophageal reflux disease (GERD) in...

at 07:16
S&P Global today reported first quarter 2024 results. The Company's earnings release and supplemental materials are available at http://investor.spglobal.com/Quarterly-Earnings. Supplemental Information/Conference Call/Webcast Details: The...

at 07:16
Huawei is presenting its innovative Intelligent Distribution Solution (IDS) at the 26th World Energy Congress in Rotterdam. Developed in collaboration with ecosystem partners, the IDS aims to tackle the electric power industry's most pressing...

at 07:15
Draganfly Inc. ("Draganfly" or the "Company"), an award-winning, industry-leading drone solutions and systems developer is pleased to announce a strategic collaboration with ParaZero Technologies Ltd., a pioneer in drone safety systems aimed at...



News published on and distributed by: